Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4073846rdf:typepubmed:Citationlld:pubmed
pubmed-article:4073846lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:4073846lifeskim:mentionsumls-concept:C0008024lld:lifeskim
pubmed-article:4073846lifeskim:mentionsumls-concept:C0238052lld:lifeskim
pubmed-article:4073846pubmed:issue4lld:pubmed
pubmed-article:4073846pubmed:dateCreated1986-1-21lld:pubmed
pubmed-article:4073846pubmed:abstractTextWe describe a patient with cerebrotendinous xanthomatosis who was treated for one year with chenodeoxycholic acid. Modest clinical improvement was accompanied by marked improvement in visual and brainstem auditory evoked potentials. Improved central nervous system function coincided with return of plasma and cerebrospinal fluid cholestanol levels to normal.lld:pubmed
pubmed-article:4073846pubmed:languageenglld:pubmed
pubmed-article:4073846pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4073846pubmed:citationSubsetIMlld:pubmed
pubmed-article:4073846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4073846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4073846pubmed:statusMEDLINElld:pubmed
pubmed-article:4073846pubmed:monthOctlld:pubmed
pubmed-article:4073846pubmed:issn0364-5134lld:pubmed
pubmed-article:4073846pubmed:authorpubmed-author:SalenGGlld:pubmed
pubmed-article:4073846pubmed:authorpubmed-author:PedleyT ATAlld:pubmed
pubmed-article:4073846pubmed:authorpubmed-author:RowlandL PLPlld:pubmed
pubmed-article:4073846pubmed:authorpubmed-author:WarnerC LCLlld:pubmed
pubmed-article:4073846pubmed:authorpubmed-author:EmersonR GRGlld:pubmed
pubmed-article:4073846pubmed:issnTypePrintlld:pubmed
pubmed-article:4073846pubmed:volume18lld:pubmed
pubmed-article:4073846pubmed:ownerNLMlld:pubmed
pubmed-article:4073846pubmed:authorsCompleteYlld:pubmed
pubmed-article:4073846pubmed:pagination517-8lld:pubmed
pubmed-article:4073846pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:meshHeadingpubmed-meshheading:4073846-...lld:pubmed
pubmed-article:4073846pubmed:year1985lld:pubmed
pubmed-article:4073846pubmed:articleTitleTreatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.lld:pubmed
pubmed-article:4073846pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:4073846pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4073846lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4073846lld:pubmed